LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 210

Search options

  1. Article ; Online: Dexamethasone and COVID-19: Strategies in Low- and Middle-Income Countries to Tackle Steroid-Related Strongyloides Hyperinfection.

    Olivera, Mario J

    The American journal of tropical medicine and hygiene

    2021  Volume 104, Issue 5, Page(s) 1611–1612

    Abstract: COVID-19 can trigger a systemic inflammatory response that in some cases leads to severe lung involvement, multisystem dysfunction, and death. Dexamethasone therapy, because of its potent anti-inflammatory effects, has been proposed for the management of ...

    Abstract COVID-19 can trigger a systemic inflammatory response that in some cases leads to severe lung involvement, multisystem dysfunction, and death. Dexamethasone therapy, because of its potent anti-inflammatory effects, has been proposed for the management of hospitalized patients with severe COVID-19. The subject of this article is to discuss potential strategies to tackle Strongyloides hyperinfection in hospitalized patients with COVID-19 receiving dexamethasone therapy in low- and middle-income countries. In this context, dexamethasone treatment has been found to be generally safe. However, its use in people coinfected with undetected Strongyloides stercoralis increases the risk for Strongyloides hyperinfection/dissemination a potentially fatal complication. Infection caused by S. stercoralis may remain asymptomatic or with mild symptoms in humans for several years. Early detection and specific treatment prevent a fatal evolution of this complication, but the challenge is to screen before corticosteroid therapy. In some cases, presumptive treatment may be justified. Ivermectin is the gold standard for treatment.
    MeSH term(s) Animals ; Developing Countries ; Dexamethasone/adverse effects ; SARS-CoV-2 ; Strongyloides stercoralis ; Strongyloidiasis/drug therapy ; Strongyloidiasis/etiology ; COVID-19 Drug Treatment
    Chemical Substances Dexamethasone (7S5I7G3JQL)
    Language English
    Publishing date 2021-03-15
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2942-7
    ISSN 1476-1645 ; 0002-9637
    ISSN (online) 1476-1645
    ISSN 0002-9637
    DOI 10.4269/ajtmh.20-1085
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Opportunity cost and COVID-19: A perspective from health economics.

    Olivera, Mario J

    Medical journal of the Islamic Republic of Iran

    2020  Volume 34, Page(s) 177

    Abstract: The substantial increase in demand for medical care in intensive care units (ICUs) caused by the recent appearance of coronavirus disease 2019 (COVID-19) has placed severe pressure on hospital beds. Although countries have intensified efforts to contain ... ...

    Abstract The substantial increase in demand for medical care in intensive care units (ICUs) caused by the recent appearance of coronavirus disease 2019 (COVID-19) has placed severe pressure on hospital beds. Although countries have intensified efforts to contain or delay the spread of COVID-19, they must prepare to cope with the growing demand for critical care inpatient beds or risk being overwhelmed by the pandemic. The subject of this paper is the COVID-19 pandemic and the opportunity cost from the perspective of health economics using the supply and demand model of hospital bed days in ICUs. In this context, it has been seen that there is an excess demand for hospital beds that exceeds the supply of bed days provided by the health system, generating opportunity costs for patients who cannot be admitted to ICUs because beds are not available. Policymakers must take into account the notion of opportunity cost to ensure that scarce resources are used efficiently because patients with and without COVID-19 will be competing for the same ICU resources.
    Language English
    Publishing date 2020-12-29
    Publishing country Iran
    Document type Editorial
    ZDB-ID 1095990-7
    ISSN 1016-1430
    ISSN 1016-1430
    DOI 10.47176/mjiri.34.177
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Malaria in the eco-epidemiological region of the Colombian Caribbean, 1960-2019.

    Acuña-Cantillo, Luis / Olivera, Mario J / Padilla-Rodríguez, Julio Cesar

    Revista peruana de medicina experimental y salud publica

    2023  Volume 39, Issue 4, Page(s) 463–468

    Abstract: Objectives.: Motivation for the study: the information available on the epidemiology of malaria in the Colombian Caribbean region is incomplete, poorly systematized and its dissemination is limited. This has led to a lack of knowledge of its magnitude ... ...

    Title translation Malaria en la región eco-epidemiológica del Caribe Colombiano, 1960-2019.
    Abstract Objectives.: Motivation for the study: the information available on the epidemiology of malaria in the Colombian Caribbean region is incomplete, poorly systematized and its dissemination is limited. This has led to a lack of knowledge of its magnitude and a low perception of its importance as a public health problem. Main findings: the behavior of malaria is endemic-epidemic, with low to very low transmission, focused and with irregular outbreaks. Plasmodium vivax infections predominate. Implications: the results of this study contribute to improve evidence-based decision making for the implementation of malaria eradication plans. Malaria has a heterogeneous and variable behavior among Colombian regions. In order to establish its epidemiological behavior in the Colombian Caribbean region between 1960 and 2019, we carried out an observational, descriptive and retrospective study based on records from the Ministry of Health and other secondary sources. We defined epidemiological variables and used measures of frequency and central tendency. A total of 155,096 cases were registered. The decades with the highest number of cases were 1990-1999 (20.5%) and 1980-1989 (18.9%). The average number of cases per decade was 25,849.3. The highest parasite rates were recorded in 1970 (3.3 per 1000 population) and 1981 (3.9 per 1000 population). Plasmodium vivax was the most frequent species and most of the burden by age group was found in people under 29 years of age, between 2010-2019. Malaria showed an endemic-epidemic pattern of low and very low transmission intensity, with a decreasing trend.
    MeSH term(s) Humans ; Adult ; Colombia/epidemiology ; Retrospective Studies ; Malaria/epidemiology ; Malaria, Vivax/epidemiology ; Caribbean Region ; Malaria, Falciparum
    Language English
    Publishing date 2023-03-06
    Publishing country Peru
    Document type Journal Article
    ZDB-ID 2120092-0
    ISSN 1726-4642 ; 1726-4642
    ISSN (online) 1726-4642
    ISSN 1726-4642
    DOI 10.17843/rpmesp.2022.394.11359
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: New Diagnostic Algorithm for Chagas Disease: Impact on Access to Diagnosis and Out-of-Pocket Expenditures in Colombia.

    Olivera, Mario J / Chaverra, Kevin A

    Iranian journal of public health

    2019  Volume 48, Issue 7, Page(s) 1379–1381

    Language English
    Publishing date 2019-08-23
    Publishing country Iran
    Document type Journal Article
    ISSN 2251-6085
    ISSN 2251-6085
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: A Retrospective Review on Severe Malaria in Colombia, 2007-2020.

    Carmona-Fonseca, Jaime / Olivera, Mario J / Yasnot-Acosta, María F

    Pathogens (Basel, Switzerland)

    2022  Volume 11, Issue 8

    Abstract: Background: Knowledge of severe malaria (SM) or complicated malaria is insufficient in all its components. The least known type is the one associated with : Methods: A descriptive, retrospective, and cross-sectional study of secondary information was ...

    Abstract Background: Knowledge of severe malaria (SM) or complicated malaria is insufficient in all its components. The least known type is the one associated with
    Methods: A descriptive, retrospective, and cross-sectional study of secondary information was performed via SIVIGILA.
    Results: There were 9881 SM cases among 1,060,950 total malaria cases in Colombia in 2007-2020: 9.31 SM cases per 1000 malaria cases. During this period, there were 7145 SM cases due to the following species:
    Conclusions: There has been a reduction in malaria incidence in Colombia in the last 10-15 years, but there has also been a strong increase in SM incidence. We suggest emphasizing the prevention of the onset of severe malaria, with the early and accurate diagnosis of plasmodial infection.
    Language English
    Publishing date 2022-08-09
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2695572-6
    ISSN 2076-0817
    ISSN 2076-0817
    DOI 10.3390/pathogens11080893
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Gastro-allergic anisakiasis: The first case reported in Colombia and a literature review

    Patiño, John A / Olivera, Mario J

    Biomedica : revista del Instituto Nacional de Salud

    2019  Volume 39, Issue 2, Page(s) 241–246

    Title translation Anisakiasis gastro-alérgica, primera descripción de un caso en Colombia y revisión bibliográfica
    MeSH term(s) Albendazole/therapeutic use ; Animals ; Anisakiasis/diagnosis ; Anisakiasis/drug therapy ; Anisakiasis/immunology ; Anisakiasis/surgery ; Anisakis/growth & development ; Anisakis/isolation & purification ; Anthelmintics/therapeutic use ; Colombia ; Combined Modality Therapy ; Female ; Fishes/parasitology ; Food Parasitology ; Gastroscopy ; Humans ; Larva ; Middle Aged ; Raw Foods/adverse effects ; Raw Foods/parasitology ; Stomach Diseases/diagnosis ; Stomach Diseases/immunology ; Stomach Diseases/parasitology ; Urticaria/etiology
    Chemical Substances Anthelmintics ; Albendazole (F4216019LN)
    Language Spanish
    Publishing date 2019-06-15
    Publishing country Colombia
    Document type Case Reports ; Journal Article ; Review
    ISSN 0120-4157
    ISSN 0120-4157
    DOI 10.7705/biomedica.v39i2.3936
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Comparison of Health-Related Quality of Life in Outpatients with Chagas and Matched Non-Chagas Chronic Heart Failure in Colombia: A Cross-Sectional Analysis.

    Olivera, Mario J / Fory, Johana A / Buitrago, Giancarlo

    The American journal of tropical medicine and hygiene

    2021  Volume 104, Issue 3, Page(s) 951–958

    Abstract: Chagas disease represents an important cause of heart failure (HF) and affects health-related quality of life (HRQoL). The study aimed to evaluate and compare the HRQoL of patients with chagasic HF and matched non-Chagas controls to identify factors ... ...

    Abstract Chagas disease represents an important cause of heart failure (HF) and affects health-related quality of life (HRQoL). The study aimed to evaluate and compare the HRQoL of patients with chagasic HF and matched non-Chagas controls to identify factors associated with HRQoL. A cross-sectional study with pair-matched controls was conducted in Colombia. From October 2018 to December 2019, a total of 84 HF patients were screened for study subjects. Four were excluded, resulting in 80 patients for the analysis, among whom 40 patients with Chagas were enrolled as cases and 40 gender- and age-matched non-Chagas patients as controls. The Kansas City Cardiomyopathy Questionnaire (KCCQ) and the Minnesota Living with Heart Failure Questionnaire (MLWHFQ) were used to measure HRQoL. Demographic, clinical, and laboratory data were obtained from each subject. Health-related quality of life scores were significantly worse among the Chagas group than among the non-Chagas group in the KCCQ domains of physical functioning and symptoms and in the MLWHFQ scale. In the multivariate analysis, the variables associated with lower HRQoL scores were living alone, obesity, having less than 12 years of education, and an increase in left ventricular diameters in the systole and diastole. Health-related quality of life in patients with chronic HF is impaired across all domains. Chagas patients showed worse HRQoL scores than non-Chagas patients. Six variables, some potentially modifiable, were independently associated with worse HRQoL.
    MeSH term(s) Aged ; Chagas Disease/psychology ; Chronic Disease/psychology ; Colombia ; Cross-Sectional Studies ; Female ; Heart Failure/psychology ; Humans ; Male ; Middle Aged ; Outpatients/psychology ; Outpatients/statistics & numerical data ; Quality of Life ; Surveys and Questionnaires
    Language English
    Publishing date 2021-02-01
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2942-7
    ISSN 1476-1645 ; 0002-9637
    ISSN (online) 1476-1645
    ISSN 0002-9637
    DOI 10.4269/ajtmh.20-0335
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Epidemiological evolution and historical anti-malarial control initiatives in Colombia, 1848-2019.

    Padilla-Rodríguez, Julio Cesar / Olivera, Mario J / Padilla-Herrera, María Cristina

    Le infezioni in medicina

    2022  Volume 30, Issue 2, Page(s) 309–319

    Abstract: The evolution of epidemiological transmission and the control measures implemented in Colombia have been the result of complex global and regional economic and political processes that occurred at different historical moments, since the dawn of the ... ...

    Abstract The evolution of epidemiological transmission and the control measures implemented in Colombia have been the result of complex global and regional economic and political processes that occurred at different historical moments, since the dawn of the country's republican life. The development of economic activities for the production, exploitation and export of agricultural products, minerals and raw materials demanded in the international market, favored the necessary conditions for the emergence, expansion, resurgence and persistence of the endemic epidemic of malaria in the different stages studied. A common and fundamental element in the different defined historical moments was the importance given to malaria as an economic problem due to the negative externalities it imposed on the labor force. In addition, due to the role it played as a barrier that limited the exploitation of natural resources and raw materials of interest; as well as the impact that it caused to the flow and commercial exchange. The previous situation was framed with the growth, consolidation and geostrategic expansion of the United States, as the main commercial partner of the region, and its interest in the exploitation of resources and raw materials, cheap labor, the need to create new markets, which coincided with the goals of modernization and economic strengthening of Colombia. Taking into account different relevant milestones that occurred in the 1848-2019 period, the following stages were defined: Epidemiological emergence and re-emergence of tropical fevers in places of economic exploitation, 1848-1899;Emergence of a new paradigm, control in enclaves of economic interest, ports and cities, 1900-1949;Control to eradication, intensified control-eradication, prevention and control, 1950-1999;Prevention, control and elimination of malaria, 2000-2019. Historically, antimalarial control initiatives in the country have been directed, restricted and prioritized in places of political and economic importance. The technical-scientific intervention measures implemented in the different stages studied have been uncritically replicated without adapting to the epidemiological scenarios existing in the country. Finally, the antimalarial control measures implemented in Colombia have been imported and adopted from international health initiatives as a result of commitments and obligations acquired in the global commercial context.
    Language English
    Publishing date 2022-06-01
    Publishing country Italy
    Document type Journal Article
    ZDB-ID 2041081-5
    ISSN 2532-8689 ; 1124-9390
    ISSN (online) 2532-8689
    ISSN 1124-9390
    DOI 10.53854/liim-3002-19
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Economic costs of Chagas disease in Colombia in 2017: A social perspective.

    Olivera, Mario J / Buitrago, Giancarlo

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

    2019  Volume 91, Page(s) 196–201

    Abstract: Objective: To quantify the costs of Chagas disease in Colombia from a societal perspective in 2017.: Methods: A cost-of-illness analysis was carried out using a prevalence-based approach. Costs attributable to Chagas were estimated from a bottom-up ... ...

    Abstract Objective: To quantify the costs of Chagas disease in Colombia from a societal perspective in 2017.
    Methods: A cost-of-illness analysis was carried out using a prevalence-based approach. Costs attributable to Chagas were estimated from a bottom-up strategy, using population attributable fractions. Indirect costs were calculated using the human capital approach.
    Results: The estimated total cost of diagnosed Chagas disease was US $13.1 million and included $5.7 million in direct medical costs, $1.5 million in direct nonmedical costs, and $5.8 million in indirect costs: absenteeism ($2.2 million), presenteeism ($3.1 million), and premature deaths ($515228). On average, people diagnosed with Chagas disease incurred $594 in medical expenses, and more than half of that expense was directly attributable to Chagas. The annual cost to society for a person with chronic Chagas disease was $4226.
    Conclusions: Chagas disease imposes a substantial financial burden on healthcare system and society. Economic cost of illness-related productivity losses is much more significant. Our research suggests that a health policy framework addressing as many of the social determinants of health as possible may be pivotal in containing social costs. Therefore, reducing this burden is not only the responsibility of the health system.
    MeSH term(s) Absenteeism ; Adolescent ; Adult ; Aged ; Chagas Disease/economics ; Colombia ; Cost of Illness ; Efficiency ; Female ; Health Care Costs ; Humans ; Male ; Middle Aged ; Prevalence ; Young Adult
    Language English
    Publishing date 2019-11-23
    Publishing country Canada
    Document type Journal Article
    ZDB-ID 1331197-9
    ISSN 1878-3511 ; 1201-9712
    ISSN (online) 1878-3511
    ISSN 1201-9712
    DOI 10.1016/j.ijid.2019.11.022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Comparison of 1-year healthcare resource utilization and related costs for patients with heart failure in the Chagas and non-Chagas matched cohorts.

    Olivera, Mario J / Arévalo, Adriana / Muñoz, Lyda / Duque, Sofía / Bedoya, Juan / Parra-Henao, Gabriel

    Therapeutic advances in infectious disease

    2022  Volume 9, Page(s) 20499361221114270

    Abstract: Background: Chagas disease is one of the leading causes of heart failure (HF) in Latin Americans, and there are limited data available that examine related costs of care for patients with HF. This study aimed to compare healthcare resource utilization ... ...

    Abstract Background: Chagas disease is one of the leading causes of heart failure (HF) in Latin Americans, and there are limited data available that examine related costs of care for patients with HF. This study aimed to compare healthcare resource utilization and related costs for patients with HF, with and without Chagas disease.
    Methods: A prospective matched-cohort study comparing the healthcare costs for patients with HF with Chagas disease and care costs for patients with HF without Chagas disease was conducted between January 2019 and December 2019. Only direct costs have been estimated, including hospitalization costs, medications and other cardiovascular interventions, and clinical and laboratory follow-up for up to 1 year.
    Results: A total of 80 patients with chronic HF were included in the study. Of the 80 patients, 40 patients in the Chagas cohort and 40 patients in the non-Chagas cohort were matched for age, insurer and sex. From a social security system perspective, the total costs for the two cohorts during the study period were U$970,136. Specifically, the healthcare costs for the Chagas cohort were greater than the total healthcare costs for the non-Chagas group (U$511,931
    Conclusions: Over a 12-month follow-up period, patients with chronic HF and Chagas consume as many healthcare resources as those with chronic HF and without Chagas. These data highlight the considerable and growing economic burden of HF on the Colombian health system.
    Language English
    Publishing date 2022-07-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 2728410-4
    ISSN 2049-937X ; 2049-9361
    ISSN (online) 2049-937X
    ISSN 2049-9361
    DOI 10.1177/20499361221114270
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top